Small molecule control of pre-mRNA splicing
Open Access
- 20 January 2005
- journal article
- Published by Cold Spring Harbor Laboratory in RNA
- Vol. 11 (3) , 355-358
- https://doi.org/10.1261/rna.7229705
Abstract
SR proteins regulate alternative splicing by binding to exonic sequences where, via an arginine/serine-rich splicing activation domain, they enhance the binding of the spliceosome to the adjacent splice sites. Here, a system is described in which a nontoxic derivative of the small molecule rapamycin is used to control pre-mRNA splicing in vitro. This involves the rapamycin-dependent recruitment of a splicing activation domain located on one protein to a second protein bound to the pre-mRNA. These results provide a new approach to explore for regulating gene expression in vivo with small molecules by controlling pre-mRNA splicing.Keywords
This publication has 20 references indexed in Scilit:
- The silent treatmentNature, 2004
- Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction MicroarraysScience, 2003
- LNA: a versatile tool for therapeutics and genomicsPublished by Elsevier ,2003
- Regulation of endogenous gene expression with a small-molecule dimerizerNature Biotechnology, 2002
- Antisense as a neuroscience tool and therapeutic agentTrends in Neurosciences, 2001
- Ribozyme gene therapy: applications for molecular medicineTrends in Molecular Medicine, 2001
- A humanized system for pharmacologic control of gene expressionNature Medicine, 1996
- Dimeric ligands define a role for transcriptional activation domains in reinitiationNature, 1996
- A Signaling Pathway to Translational ControlCell, 1996
- Molecular cloning and overexpression of the human FK506-binding protein FKBPNature, 1990